Shelby Shimberg, PA
Surgical · Atlanta, GANPI 1265022537
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 195 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. Among surgical clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 195 payments — averaging $39.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Teleflex LLC$1K
- Johnson & Johnson$417
- Endo Pharmaceuticals Inc.$395
- Sumitomo Pharma America, Inc.$372
- Myovant Sciences Inc.$345
- plus $3K from 31 others
What the payments were for
- Food & beverage$7,45098%
- Education$1772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 20 | $1,745 |
| Teleflex LLC | 17 | $1,405 |
| Johnson & Johnson | 4 | $417 |
| Endo Pharmaceuticals Inc. | 15 | $395 |
| Sumitomo Pharma America, Inc. | 20 | $372 |
| Myovant Sciences Inc. | 12 | $345 |
| Bayer | 15 | $321 |
| Coloplast | 7 | $294 |
| Merck | 9 | $234 |
| Antares Pharma, Inc. | 11 | $202 |
| Pfizer | 6 | $195 |
| Dendreon Pharmaceuticals LLC | 3 | $192 |
| Astellas Pharma US Inc | 8 | $189 |
| Procept Biorobotics Corporation | 3 | $179 |
| Myriad Genetic Laboratories, Inc. | 4 | $173 |
| Verity Pharmaceuticals Inc. | 8 | $152 |
| Blue Earth Diagnostics | 4 | $95 |
| Baxter Healthcare | 1 | $81 |
| Endo USA, Inc. | 3 | $77 |
| Tolmar Pharmaceuticals, Inc. | 3 | $60 |
| Convatec Inc. | 2 | $52 |
| Tolmar, Inc. | 2 | $44 |
| Davol Inc. | 2 | $36 |
| Halozyme Inc | 2 | $35 |
| Urogen Pharma, Inc. | 1 | $35 |
| Urovant Sciences Inc | 1 | $34 |
| Sun Pharmaceutical Industries Inc. | 1 | $33 |
| Olympus America Inc. | 2 | $29 |
| Laborie Medical Technologies Corp. | 1 | $29 |
| Novartis | 1 | $28 |
| ABC Home Medical Supply, Inc. | 1 | $25 |
| Boston Scientific | 1 | $24 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $22 |
| 180 Medical, Inc. | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Dentsply IH AB | 1 | $19 |
| Progenics Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,627 in reported general payments places this provider in the 95th percentile of 372 surgical providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 21 | $18,123 |
| MyrbetriqMirabegron | 20 | $14,281 |
| Methenamine Hippurate | 108 | $4,462 |
| YuvafemEstradiol | 23 | $2,119 |
| Estradiol | 20 | $1,666 |
| Trimethoprim | 17 | $881 |
| Solifenacin Succinate | 15 | $709 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 31 | $706 |
| Finasteride | 44 | $521 |
| NitrofurantoinNitrofurantoin Macrocrystal | 11 | $421 |
| Tamsulosin Hcl | 34 | $379 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 34 | $316 |
| CefuroximeCefuroxime Axetil | 47 | $252 |
| Tramadol Hcl | 57 | $67 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $50 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $372 | $18,12321 claims |
| Astellas Pharma US IncMyrbetriq | $189 | $14,28120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 372 surgical providers in Georgia.
Other surgical in Atlanta
- Michael BerkeAtlanta$242K
- Emily WatsonAtlanta$150K
- William JohnsonAtlanta$8K
- Julie ShoffstallAtlanta$7K
- Brian MullinAtlanta$5K
- Caroline HerambAtlanta$5K
- David EllingsonAtlanta$5K
- Marquitha MayfieldAtlanta$4K
- Ashley MajoskeyAtlanta$4K
- Shenika GarnerAtlanta$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.